Independent Director Director Since: 2016 Age: 58 Committee Service: Audit Compensation (Chair) Professional Experience: Managing Director, Alta Partners (2016 2025) Senior Advisor, Bill & Melinda Gates Foundation (2013 2015) General Partner, Frazier Healthcare Ventures (2008 2013) General Partner, Domain Associates (1996 2008) Education: B.S., Biology, Middlebury College MBA, Darden School of Business Administration at the University of Virginia Other Public Company Boards: Tyra Biosciences, Inc. (Chairman) (2021 present) Sienna Biopharmaceuticals, Inc. (2017 2019) Glaukos Corporation (2015) Other Affiliations: Service on the boards of directors for various private biotechnology and life sciences companies Service on the boards of directors for non-profit organizations, including: The Kauffman Fellows Program (founding member); One Revolution; and The Foundation for Innovative New Diagnostics Prior service on Emerging Companies Section Governing Board, Biotechnology Innovation Organization (BIO) The Nominating and Corporate Governance Committee and Board believe that Mr. More is qualified to serve on the Board due to his experience serving on the boards of directors of clinical-stage biotechnology companies, his extensive experience as a director of public companies and his investment experience in the life sciences industry.